Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.71 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15653578 | 1.00 | TDP1 (0.71) | TDP1ABCB1POLBMAPK1 | |
| SCHEMBL15484170 | 1.00 | TDP1 (0.71) | TDP1ABCB1POLBMAPK1 | |
| SCHEMBL29529175 | 1.00 | TDP1 (0.71) | TDP1ABCB1POLBMAPK1 | |
| SCHEMBL60713 | 1.00 | TDP1 (0.71) | TDP1ABCB1POLBMAPK1 | |
| SCHEMBL421756 | 1.00 | TDP1 (0.71) | TDP1ABCB1POLBMAPK1 | |
| SCHEMBL13893402 | 1.00 | TDP1 (0.71) | TDP1ABCB1POLBMAPK1 | |
| Potassium SCHEMBL30587676 | 0.98 | TDP1 (0.69) | TDP1ABCB1POLBMAPK1 | |
| Hydrochloric Acid SCHEMBL30259230 | 0.98 | TDP1 (0.69) | TDP1ABCB1POLBMAPK1 | |
| SCHEMBL8587285 | 0.95 | TDP1 (0.68) | TDP1ABCB1POLBMAPK1 | |
| SCHEMBL2279600 | 0.95 | TDP1 (0.68) | TDP1ABCB1POLBMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 256 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118812628-A | Mannosylated seryl cystatin dioleamine compound, and preparation method and application thereof | 制能(北京)生物科技有限公司 | 2024-10-22 | — | — | CN | claimed |
| CN-118724988-A | Glycosylated amino acid preparation method and glycosylated polypeptide preparation method | 上海科泽永欣生物科技有限公司 | 2024-10-01 | — | — | CN | claimed |
| CN-104031108-B | A kind of fluorescent chemicals and preparation method thereof and the methods and applications utilizing this fluorescent chemicals to prepare sense film | SHAANXI NORMAL UNIVERSITY (CN) | 2016-04-13 | — | — | CN | claimed |
| US-20130217640-A1 | GLYCOSYLATED ACETAMINOPHEN PRO-DRUG | NuTek Pharma Ltd. | 2013-08-22 | — | — | US | claimed |
| WO-2012012339-A2 | GLYCOSYLATED ACETAMINOPHEN PRO-DRUG ANALOGS | NuTek Pharma Ltd. (US) | 2012-01-26 | — | — | WO | claimed |
| CN-100591812-C | Preparation method of glycosylated nano-fibre for identifying protein and applications | UNIV ZHEJIANG | 2010-02-24 | — | — | CN | claimed |
| CN-100444942-C | Glycosylated polyethylene affinity membrane preparing method and its use | UNIV ZHEJIANG (CN) | 2008-12-24 | — | — | CN | claimed |
| CN-101285221-A | Preparation method of glycosylated nano-fibre for identifying proteinicsubstance and applications | UNIV ZHEJIANG (CN) | 2008-10-15 | — | — | CN | claimed |
| CN-1935342-A | Glycosylated polyethylene affinity membrane preparing method and its use | UNIV ZHEJIANG (CN) | 2007-03-28 | — | — | CN | claimed |
| JP-5301905-A | — | — | None | — | — | JP | disclosed |
| US-12617813-B2 | Glycosylated histone deacetylase inhibitors and methods of making and using the same | GEORGIA TECH RESEARCH CORPORATION (US) | 2026-05-05 | — | — | US | disclosed |
| EP-4698568-A1 | PARTICLES OF HYDROPHOBIC-CHAIN-MODIFIED MONOSACCHARIDES AND CYCLODEXTRIN | Paris Sciences et Lettres (FR) | 2026-02-25 | — | — | EP | disclosed |
| EP-4662322-A1 | SQUARAMIDE-MODIFIED ADENO-ASSOCIATED VIRUS VECTORS | Coave Therapeutics (FR) | 2025-12-17 | — | — | EP | disclosed |
| US-20250236685-A1 | DEGRADABLE POLYMERS | THE TRUSTEES OF BOSTON COLLEGE | 2025-07-24 | — | — | US | disclosed |
| JP-H05301905-A | HCG-RELATING NONASACCHARINE HAPTEN | TOWA KASEI KOGYO KK | 1993-11-16 | — | — | JP | disclosed |
| EP-0537187-A1 | PROCESS FOR PRODUCING ACYLATED GLYCOSYL FLUORIDES. | HOECHST AG (DE) | 1993-04-21 | — | — | EP | disclosed |
| WO-1992000308-A1 | PROCESS FOR PRODUCING ACYLATED GLYCOSYL FLUORIDES | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-01-09 | — | — | WO | disclosed |
| US-4873322-A | VIRICIDES, HERPES AND INFLUENZA; LINKED TO CEPHALIN COMPONENTS | CIBA-GEIGY CORPORATION (US) | 1989-10-10 | — | — | US | disclosed |
| EP-0095904-B1 | DETERGENT LIQUORS AND COMPOSITIONS FOR USE THEREIN | THE PROCTER & GAMBLE COMPANY (US) | 1986-09-03 | — | — | EP | disclosed |
| US-4228274-A | 1-Substituted glycopyranosides | MERCK & CO., INC. (US) | 1980-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12617813-B2 | Glycosylated histone deacetylase inhibitors and methods of making and using the same | HDAC3, HDAC1, HDAC11 | TDP1 1940/4885ABCB1 2909/4885POLB 1351/4885 |
| US-20130217640-A1 | GLYCOSYLATED ACETAMINOPHEN PRO-DRUG | UGT1A3, GCG, UGGT1 | TDP1 2617/4885ABCB1 51/4885POLB 4072/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.